WallStreetZenWallStreetZen

NASDAQ: SGMO
Sangamo Therapeutics Inc Stock Ownership - Who owns Sangamo Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Sangamo Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Sandy MacRaePRESIDENT CEO AND DIRECTOR2025-04-22126,950$0.78
$98.51kSell
Nathalie DuboisstringfellowSVP-CHIEF DEVELOPMENT OFFICER2025-04-2231,866$0.78
$24.73kSell
Prathyusha DuraibabuSVP CHIEF FINANCIAL OFFICER2025-04-2231,866$0.78
$24.73kSell
Gregory D. DavisHead of Research Technology2025-04-226,708$0.78
$5.21kSell
Scott B. WilloughbySVP GEN. COUNSEL SECRETARY2025-04-2231,866$0.78
$24.73kSell
Prathyusha DuraibabuSVP CHIEF FINANCIAL OFFICER2025-02-251,375$0.96
$1.31kSell
Sandy MacRaePRESIDENT CEO AND DIRECTOR2025-02-2510,663$0.96
$10.19kSell
Nathalie DuboisstringfellowSVP-CHIEF DEVELOPMENT OFFICER2025-02-251,513$0.96
$1.45kSell
Scott B. WilloughbySVP GEN. COUNSEL SECRETARY2025-02-251,375$0.96
$1.31kSell
Gregory D. DavisHead of Research Technology2025-02-25507$0.96
$484.69Sell

1 of 6

SGMO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SGMO insiders and whales buy or sell their stock.

SGMO Shareholders

What type of owners hold Sangamo Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Biogen Inc7.86%17,652,466$12.73MInsider
Vanguard Group Inc4.17%9,374,728$6.76MInstitution
Wasatch Advisors LP4.11%9,231,505$6.66MInstitution
Blackrock Inc2.31%5,193,304$3.74MInstitution
State Street Corp2.23%5,019,035$3.62MInstitution
Ra Capital Management LP1.64%3,683,002$2.66MInsider
Renaissance Technologies LLC1.37%3,084,877$2.22MInstitution
Millennium Management LLC1.22%2,739,666$1.98MInstitution
Sandy MacRae1.04%2,325,898$1.68MInsider
Point72 Asset Management LP1.01%2,270,550$1.64MInstitution

1 of 3

SGMO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SGMO27.37%14.33%Net SellingNet Selling
ACIU27.26%0.00%
SLN17.50%0.09%
PRQR42.22%0.00%
LRMR53.68%46.32%
View Top Biotech Stocks

Sangamo Therapeutics Stock Ownership FAQ

Who owns Sangamo Therapeutics?

Sangamo Therapeutics (NASDAQ: SGMO) is owned by 27.37% institutional shareholders, 14.33% Sangamo Therapeutics insiders, and 58.29% retail investors. Biogen Inc is the largest individual Sangamo Therapeutics shareholder, owning 17.65M shares representing 7.86% of the company. Biogen Inc's Sangamo Therapeutics shares are currently valued at $13.63M.

If you're new to stock investing, here's how to buy Sangamo Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.